Adhera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 1986
Net Income	2.35	-7.78	-5.54	-12.64	-16.75	-6.22	-0.84	3.34	-6.48	-1.57	Upgrade
Depreciation & Amortization	1.81	0.4	0.4	0.08	0.33	0.45	0.05	0	0	2.01	Upgrade
Share-Based Compensation	0	0	0.01	0.77	1.45	0.42	0	0.5	0.28	0.14	Upgrade
Other Operating Activities	-5.58	6.72	4.54	3.06	5.37	4.08	0.27	-6.01	1.42	-0.29	Upgrade
Operating Cash Flow	-1.42	-0.67	-0.59	-8.74	-9.61	-1.26	-0.52	-2.17	-4.78	0.29	Upgrade
Capital Expenditures	0	0	0	0	-0.07	-0.38	0	-0.05	0	0	Upgrade
Acquisitions	0	0	0	0	0	0	0.01	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	0.41	Upgrade
Investing Cash Flow	0	0	0	0	-0.07	-0.38	0.01	-0.05	0	0.41	Upgrade
Dividends Paid	-0.62	-2.05	-1.54	-1.51	-1.06	0	0	-0.69	-6	0	Upgrade
Common Stock Issued	5.06	0.12	0.02	0	13.89	0.25	3.67	0.21	3.52	0	Upgrade
Share Repurchases	-0	-0.74	-0.54	-0.1	-0.25	0	0	0.07	8.44	0	Upgrade
Other Financing Activities	-3.07	1.94	1.52	6.27	0.42	1.39	-3.31	1.64	16.61	-0	Upgrade
Financing Cash Flow	1.37	0.74	0.54	4.87	13.5	1.64	0.36	1.1	5.69	-0	Upgrade
Net Cash Flow	-0.04	0.07	-0.05	-3.87	3.81	0	-0.16	-1.11	0.92	0.69	Upgrade
Free Cash Flow	-1.42	-0.67	-0.59	-8.74	-9.69	-1.64	-0.52	-2.21	-4.78	0.29	Upgrade
Free Cash Flow Margin	-	-	-	-3467.46%	-12713.36%	-	-	-325.00%	-955.80%	13.48%	Upgrade
Free Cash Flow Per Share	-0.61	-1.02	-1.08	-16.12	-17.87	-3.33	-2.20	-13.44	-38.80	3.37	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.